-+ 0.00%
-+ 0.00%
-+ 0.00%

ENLIVEN THERAPEUTICS - ON TRACK TO INITIATE ENABLE-2 PHASE 3 TRIAL BEFORE YEAR-END 2026

Reuters·10/06/2026 20:08:32